International Patent: METHODS AND COMPOSITIONS RELATING TO FACIOGENITAL DYSPLASIA 1 (FGD1) SPLICE VARIANTS IN CANCERS

GENEVA, Sept. 7 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. filed a patent application (US2026/016889) for “METHODS AND COMPOSITIONS RELATING TO FACIOGENITAL DYSPLASIA 1 (FGD1) SPLICE VARIANTS IN CANCERS”. With publication no. WO/2026/183353, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/6886

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....